ArticleJournal of the American Heart Association2025
Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients admitted for heart failure with preserved ejection fraction (HFpEF) are at risk for rehospitalization, especially within 90 days post discharge. NPs (natriuretic peptides), namely ANP (atrial NP) and BNP (brain NP), are important biomarkers in HF management, but their role in predicting early rehospitalization in patients with HFpEF remains unclear.
methodsA retrospective analysis was conducted on 147 patients with HFpEF hospitalized for HF. ANP and BNP levels were measured at admission and discharge. Rehospitalization events were analyzed to evaluate the prognostic impact of NPs.
resultsAmong 147 patients, 47 (32.0%) were rehospitalized within 1 year, including 22 (15.0%) within the 90 days postdischarge. Elevated discharge ANP (>113 pg/mL) was significantly associated with early rehospitalization (log-rank
conclusionsDischarge ANP was a robust predictor of early rehospitalization in patients with HFpEF. These findings suggest that incorporating ANP measurements into postdischarge management may improve risk stratification to reduce early rehospitalization in patients with HFpEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.